JB Chemicals and Pharmaceuticals Ltd recalls
3 notices naming JB Chemicals and Pharmaceuticals Ltd as the recalling firm, since October 29, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Contamination
JB Chemicals and Pharmaceuticals Ltd: Cetirizine Hydrochloride Tablets USP 5 mg
Hazard (FDA): Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.
FDAMedicines
JB Chemicals and Pharmaceuticals Ltd: Enalapril Maleate Tablets
Hazard (FDA): Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test
FDAMedicines
JB Chemicals and Pharmaceuticals Ltd: Cetirizine Hydrochloride Tablets USP 10 mg and 1 more
Hazard (FDA): Tablet/Capsules Imprinted with Wrong ID
FDAMedicines